Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein

C. T. Baldari, G. Pelicci, M. M. Di Somma, E. Milia, S. Giuli, P. G. Pelicci, J. L. Telford

Research output: Contribution to journalArticlepeer-review

Abstract

T-cell antigen receptor stimulation results in phosphorylation of the SH2 containing Shc proteins and recruitment of the Grb2/mSos complex suggesting that Shc proteins are involved in transducing T-cell activating signals to Ras. We have measured the effects of the isolated Shc-SH2 domain and the dominant negative Ras(N17) protein on activation of the T-cell specific transcription factor NF-AT. The isolated Shc-SH2 domain was designed to compete with endogenous Shc binding to upstream tyrosine phosphorylated proteins and to interfere with coupling to regulators of Ras activation. We have demonstrated that both the Shc-SH2 domain and the Ras(N17) protein significantly inhibited NF-AT activation by the CD4 coreceptor and the CD4 associated tyrosine kinase p56(lck). In contrast, only the Ras(N17) protein reduced NF-AT activation by the TCR/CD3 complex. Furthermore, tyrosine kinase activity and p56(lck) protein were found in complexes immunoprecipitated with Shc specific antisera after CD4 triggering but not after CD3 triggering. These results indicate that both CD4 and CD3 signal to Ras and that this signaling is mediated by independent pathways of activation of the Shc adaptor protein.

Original languageEnglish
Pages (from-to)1141-1147
Number of pages7
JournalOncogene
Volume10
Issue number6
Publication statusPublished - 1995

Keywords

  • Ras
  • T-cell activation
  • Tyrosine phosphorylation

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein'. Together they form a unique fingerprint.

Cite this